Lv Yong-Bo, Wang Yang, Ma Wang-Ge, Yan Ding-Yi, Zheng Wen-Ling, Chu Chao, Guo Tong-Shuai, Yuan Zu-Yi, Mu Jian-Jun
Department of Cardiology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
Key Laboratory of Molecular Cardiology of Shaanxi Province, Xi'an, China.
PLoS One. 2016 Jul 19;11(7):e0158880. doi: 10.1371/journal.pone.0158880. eCollection 2016.
BACKGROUND/AIMS: Two renalase single nucleotide polymorphisms (SNPs) rs2296545 and rs2576178 have been reported to be associated with the susceptibility to hypertension (HT). Given the inconsistent results, we conducted a meta-analysis to assess the association between these two SNPs and the risk of HT.
Electronic databases were systematically searched to find relevant studies. Subgroup analysis was conducted according to the different concomitant diseases and ethnicities in the study population. Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated using fixed-effect or random-effect models.
A total of six case-control studies on rs2296545 and six studies on rs2576178 were included. In the combined analysis, results showed a significant association between SNP rs2296545 and risk of HT in all genetic models (dominant model CG+CC/GG: OR = 1.43, 95% CI = 1.24-1.65; recessive model CC/CG+GG: OR = 1.36, 95% CI = 1.09-1.69; codominant model CC/GG: OR = 1.63, 95% CI = 1.20-2.20, CG/GG: OR = 1.30, 95% CI = 1.12-1.52; allelic model C/G: OR = 1.29, 95% CI = 1.10-1.51). In subgroup analysis, we observed a significant association between rs2296545 and risk of essential HT. Although we did not observe an association between rs2576178 polymorphism and HT in the combined analysis, an increased risk was observed in the essential HT patients versus healthy controls (subgroup 1) analysis under the dominant, recessive, and codominant genetic models.
Renalase gene rs2296545 polymorphism is significantly associated with increased risk of HT, whereas rs2576178 polymorphism may not be associated with the susceptibility to HT.
背景/目的:据报道,肾酶的两个单核苷酸多态性(SNP)rs2296545和rs2576178与高血压(HT)易感性相关。鉴于结果不一致,我们进行了一项荟萃分析,以评估这两个SNP与HT风险之间的关联。
系统检索电子数据库以查找相关研究。根据研究人群中不同的伴随疾病和种族进行亚组分析。使用固定效应或随机效应模型计算合并比值比(OR)和95%置信区间(CI)。
共纳入6项关于rs2296545的病例对照研究和6项关于rs2576178的研究。在合并分析中,结果显示SNP rs2296545与所有遗传模型中的HT风险之间存在显著关联(显性模型CG + CC/GG:OR = 1.43,95%CI = 1.24 - 1.65;隐性模型CC/CG + GG:OR = 1.36,95%CI = 1.09 - 1.69;共显性模型CC/GG:OR = 1.63,95%CI = 1.20 - 2.20,CG/GG:OR = 1.30,95%CI = 1.12 - 1.52;等位基因模型C/G:OR = 1.29,95%CI = 1.10 - 1.51)。在亚组分析中,我们观察到rs2296545与原发性HT风险之间存在显著关联。虽然在合并分析中我们未观察到rs2576178多态性与HT之间的关联,但在原发性HT患者与健康对照(亚组1)分析中,在显性、隐性和共显性遗传模型下观察到风险增加。
肾酶基因rs2296545多态性与HT风险增加显著相关,而rs2576178多态性可能与HT易感性无关。